Business
Cannabis dispensary giant MedMen boosts U.S. footprint with major deal
MedMen Enterprises Inc., one of the most prominent companies in the expanding cannabis industry, agreed to buy medical pot firm PharmaCann for $682 million, boosting its presence across the U.S.
